Quantitative Positron Emission Tomography Studies of the Serotonin Transporter in Humans Previously Treated with the Appetite Suppressants Fenfluramine or Dexfenfluramine
暂无分享,去创建一个
Z. Szabo | U. McCann | R. Dannals | G. Ricaurte | G. Wand | M. Vranesic | Esen Seckin | A. Duval | George A. Ricaurte | Una D. McCann | U. Mccann
[1] Robert B. Innis,et al. Sex Differences in Diencephalon Serotonin Transporter Availability in Major Depression , 2006, Biological Psychiatry.
[2] E. Colman. Anorectics on Trial: A Half Century of Federal Regulation of Prescription Appetite Suppressants , 2005, Annals of Internal Medicine.
[3] Zsolt Szabo,et al. Quantitative PET Studies of the Serotonin Transporter in MDMA Users and Controls Using [11C]McN5652 and [11C]DASB , 2005, Neuropsychopharmacology.
[4] Ralph Buchert,et al. A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters. , 2004, The American journal of psychiatry.
[5] Zsolt Szabo,et al. Positron emission tomography imaging of the serotonin transporter in subjects with a history of alcoholism , 2004, Biological Psychiatry.
[6] Mark Slifstein,et al. Comparative evaluation of serotonin transporter radioligands 11C-DASB and 11C-McN 5652 in healthy humans. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[7] J. Hornung,et al. The human raphe nuclei and the serotonergic system , 2003, Journal of Chemical Neuroanatomy.
[8] M. Verbaten. Specific memory deficits in ecstasy users? The results of a meta‐analysis , 2003, Human psychopharmacology.
[9] Ralph Buchert,et al. Long-term effects of "ecstasy" use on serotonin transporters of the brain investigated by PET. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[10] John Hilton,et al. Comparison of (+)-11C-McN5652 and 11C-DASB as Serotonin Transporter Radioligands Under Various Experimental Conditions , 2002 .
[11] Zsolt Szabo,et al. Modified Regression Model for the Logan Plot , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[12] M Fujita,et al. Sex differences in [123I]β‐CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers , 2001, Synapse.
[13] S. Houle,et al. Novel Radiotracers for Imaging the Serotonin Transporter by Positron Emission Tomography: Synthesis, Radiosynthesis, and in Vitro and ex Vivo Evaluation of (11)C-Labeled 2-(Phenylthio)araalkylamines. , 2000, Journal of medicinal chemistry.
[14] D. Wong,et al. Column-switching HPLC for the analysis of plasma in PET imaging studies. , 2000, Nuclear medicine and biology.
[15] M. Kraut,et al. Kinetic Analysis of [11C]McN5652: A Serotonin Transporter Radioligand , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[16] Z. Szabo,et al. Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings , 1998, The Lancet.
[17] Z. Szabo,et al. In vivo detection of short‐ and long‐term MDMA neurotoxicity—a positron emission tomography study in the living baboon brain , 1998, Synapse.
[18] W. Edwards,et al. Valvular heart disease associated with fenfluramine-phentermine. , 1997, The New England journal of medicine.
[19] H. Preval,et al. Psychotic episode associated with dexfenfluramine. , 1997, The American journal of psychiatry.
[20] C. Raison,et al. Psychotic mania associated with fenfluramine and phentermine use. , 1997, The American journal of psychiatry.
[21] Z. Szabo,et al. Fenfluramine‐induced loss of serotonin transporters in baboon brain visualized with PET , 1996, Synapse.
[22] P. Dodd,et al. The nature ofd,l-fenfluramine-induced 5-HT reuptake transporter loss in rats , 1995, Molecular Neurobiology.
[23] H. Pijl,et al. Major depression during dexfenfluramine treatment. , 1994, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.
[24] U. McCann,et al. Dexfenfluramine and serotonin neurotoxicity: further preclinical evidence that clinical caution is indicated. , 1994, The Journal of pharmacology and experimental therapeutics.
[25] S. Garattini,et al. The role of d-norfenfluramine in the indole-depleting effect of d-fenfluramine in the rat. , 1993, European journal of pharmacology.
[26] Michael P. Johnson,et al. Comparative serotonin neurotoxicity of the stereoisomers of fenfluramine and norfenfluramine , 1990, Pharmacology Biochemistry and Behavior.
[27] J. Contrera,et al. Effects of repeated fenfluramine administration on indices of monoamine function in rat brain: pharmacokinetic, dose response, regional specificity and time course data. , 1990, The Journal of pharmacology and experimental therapeutics.
[28] M. Molliver,et al. Anatomic evidence for a neurotoxic effect of (±)-fenfluramine upon serotonergic projections in the rat , 1990, Brain Research.
[29] L. Seiden,et al. D-, L- and DL-fenfluramine cause long-lasting depletions of serotonin in rat brain , 1989, Brain Research.
[30] J. Contrera,et al. Fenfluramine selectively and differentially decreases the density of serotonergic nerve terminals in rat brain: evidence from immunocytochemical studies. , 1989, The Journal of pharmacology and experimental therapeutics.
[31] L. Seiden,et al. Effect of depletion of brain serotonin by repeated fenfluramine on neurochemical and anorectic effects of acute fenfluramine. , 1988, The Journal of pharmacology and experimental therapeutics.
[32] A. G. Zacchei,et al. FENFLURAMINE AND BRAIN SEROTONIN , 1978, Annals of the New York Academy of Sciences.
[33] J. Harvey,et al. Comparison between the neurotoxic and serotonin-depleting effects of various halogenated derivatives of amphetamine in the rat. , 1977, The Journal of pharmacology and experimental therapeutics.
[34] T. Harding. Depression Following Fenfluramine Withdrawal , 1972, British Journal of Psychiatry.
[35] T. Harding. Fenfluramine dependence. , 1971, British medical journal.
[36] M. Briggs,et al. Drugs of Dependence Though Not of Abuse: Fenfluramine and Imipramine , 1971, British medical journal.
[37] D. Hawks. Unusual effect of fenfluramine. , 1970, British medical journal.
[38] T. Darby. On Division of the Stricture in Strangulated Hernia , 1868, British medical journal.
[39] V. Arango,et al. Serotonin brain circuits involved in major depression and suicide. , 2002, Progress in brain research.
[40] John Hilton,et al. Comparison of (+)-(11)C-McN5652 and (11)C-DASB as serotonin transporter radioligands under various experimental conditions. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[41] John Hilton,et al. as Serotonin Transporter Radioligands Under Various Experimental Conditions , 2002 .
[42] D. Murphy,et al. Brain serotonin neurotransmission: an overview and update with an emphasis on serotonin subsystem heterogeneity, multiple receptors, interactions with other neurotransmitter systems, and consequent implications for understanding the actions of serotonergic drugs. , 1998, The Journal of clinical psychiatry.
[43] L. Seiden,et al. Fenfluramine: neurotoxicity. , 1986, Psychopharmacology bulletin.
[44] E. sanders-Bush,et al. Long-term effects of p-chloroamphetamine and related drugs on central serotonergic mechanisms. , 1975, The Journal of pharmacology and experimental therapeutics.
[45] Harvey Ja,et al. Fenfluramine: evidence for a neurotoxic action on midbrain and a long-term depletion of serotonin. , 1975, Psychopharmacology communications.